Drug Approval | April 24, 2023
Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
The award recognizes and supports promising female scientists working in mass spectrometry
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes
Subscribe To Our Newsletter & Stay Updated
